Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 6.73082238 |
2 | growth hormone receptor signaling pathway (GO:0060396) | 5.60214740 |
3 | NIK/NF-kappaB signaling (GO:0038061) | 5.39371130 |
4 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.36785835 |
5 | regulation of sequestering of triglyceride (GO:0010889) | 5.12273637 |
6 | cellular response to growth hormone stimulus (GO:0071378) | 4.80766228 |
7 | negative regulation of interleukin-12 production (GO:0032695) | 4.72814916 |
8 | response to peptidoglycan (GO:0032494) | 4.71919858 |
9 | brown fat cell differentiation (GO:0050873) | 4.61719144 |
10 | white fat cell differentiation (GO:0050872) | 4.59636130 |
11 | regulation of fever generation (GO:0031620) | 4.58753019 |
12 | valine metabolic process (GO:0006573) | 4.51621622 |
13 | regulation of cholesterol storage (GO:0010885) | 4.42097045 |
14 | regulation of vitamin metabolic process (GO:0030656) | 4.27509006 |
15 | triglyceride catabolic process (GO:0019433) | 4.17914392 |
16 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.17087526 |
17 | negative regulation of granulocyte differentiation (GO:0030853) | 4.16536018 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13172813 |
19 | biotin metabolic process (GO:0006768) | 4.12268634 |
20 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.12126642 |
21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.04189633 |
22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03058924 |
23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.03058924 |
24 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.95992434 |
25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92241072 |
26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.81698916 |
27 | fatty acid transmembrane transport (GO:1902001) | 3.79899403 |
28 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.78539693 |
29 | germinal center formation (GO:0002467) | 3.75859123 |
30 | response to dietary excess (GO:0002021) | 3.72813410 |
31 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.71545684 |
32 | regulation of podosome assembly (GO:0071801) | 3.68298738 |
33 | lipid storage (GO:0019915) | 3.67078454 |
34 | acylglycerol catabolic process (GO:0046464) | 3.65971767 |
35 | neutral lipid catabolic process (GO:0046461) | 3.65971767 |
36 | regulation of chronic inflammatory response (GO:0002676) | 3.64108507 |
37 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.60759876 |
38 | T-helper 1 type immune response (GO:0042088) | 3.60571867 |
39 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.58113087 |
40 | regulation of chemokine biosynthetic process (GO:0045073) | 3.57646642 |
41 | positive regulation of macrophage cytokine production (GO:0060907) | 3.56871225 |
42 | carnitine shuttle (GO:0006853) | 3.56703804 |
43 | negative regulation of lipid storage (GO:0010888) | 3.56350439 |
44 | positive regulation of histone deacetylation (GO:0031065) | 3.54674915 |
45 | regulation of mononuclear cell migration (GO:0071675) | 3.50117608 |
46 | negative regulation of phagocytosis (GO:0050765) | 3.47436546 |
47 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.46185136 |
48 | positive regulation of heat generation (GO:0031652) | 3.40534901 |
49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38091763 |
50 | adaptation of signaling pathway (GO:0023058) | 3.35739226 |
51 | negative regulation of protein autophosphorylation (GO:0031953) | 3.34996416 |
52 | positive regulation of cholesterol efflux (GO:0010875) | 3.31430975 |
53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30019710 |
54 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.29772880 |
55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27370950 |
56 | positive regulation of p38MAPK cascade (GO:1900745) | 3.24732341 |
57 | regulation of interferon-alpha production (GO:0032647) | 3.22762130 |
58 | type I interferon signaling pathway (GO:0060337) | 3.18386641 |
59 | cellular response to type I interferon (GO:0071357) | 3.18386641 |
60 | response to muramyl dipeptide (GO:0032495) | 3.14866067 |
61 | response to type I interferon (GO:0034340) | 3.14624699 |
62 | triglyceride biosynthetic process (GO:0019432) | 3.09832290 |
63 | serine transport (GO:0032329) | 3.08376350 |
64 | positive regulation of type 2 immune response (GO:0002830) | 3.07183303 |
65 | positive regulation of sterol transport (GO:0032373) | 3.07045105 |
66 | positive regulation of cholesterol transport (GO:0032376) | 3.07045105 |
67 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.06607428 |
68 | positive regulation of lipid storage (GO:0010884) | 3.06128326 |
69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05908537 |
70 | positive regulation of acute inflammatory response (GO:0002675) | 3.05663174 |
71 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.05619862 |
72 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.04314288 |
73 | positive regulation of fatty acid oxidation (GO:0046321) | 3.03824215 |
74 | activation of MAPKKK activity (GO:0000185) | 3.03209196 |
75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02853580 |
76 | detection of molecule of bacterial origin (GO:0032490) | 3.02567614 |
77 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.98974258 |
78 | cellular response to lipopolysaccharide (GO:0071222) | 2.97525869 |
79 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.95337162 |
80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95095342 |
81 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93320967 |
82 | response to protozoan (GO:0001562) | 2.93254853 |
83 | defense response to protozoan (GO:0042832) | 2.92588200 |
84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.92032391 |
85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91818579 |
86 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91679078 |
87 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.91116077 |
88 | cellular response to molecule of bacterial origin (GO:0071219) | 2.89922832 |
89 | neutral lipid biosynthetic process (GO:0046460) | 2.89706873 |
90 | acylglycerol biosynthetic process (GO:0046463) | 2.89706873 |
91 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.89477990 |
92 | lipid particle organization (GO:0034389) | 2.87903100 |
93 | skeletal muscle adaptation (GO:0043501) | 2.86321052 |
94 | neutrophil activation involved in immune response (GO:0002283) | 2.85348613 |
95 | immunoglobulin mediated immune response (GO:0016064) | 2.84536812 |
96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84373605 |
97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84154819 |
98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.83746090 |
99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.83393671 |
100 | carnitine transmembrane transport (GO:1902603) | 2.83312052 |
101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82984346 |
102 | negative regulation of amino acid transport (GO:0051956) | 2.82005496 |
103 | myeloid dendritic cell differentiation (GO:0043011) | 2.80241398 |
104 | negative regulation of innate immune response (GO:0045824) | 2.79390000 |
105 | macrophage activation (GO:0042116) | 2.79266030 |
106 | regulation of lipid storage (GO:0010883) | 2.77439786 |
107 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.77281143 |
108 | ovulation from ovarian follicle (GO:0001542) | 2.76929809 |
109 | monocyte chemotaxis (GO:0002548) | 2.76338147 |
110 | macrophage activation involved in immune response (GO:0002281) | 2.74485699 |
111 | regulation of type 2 immune response (GO:0002828) | 2.73462850 |
112 | intracellular lipid transport (GO:0032365) | 2.72779160 |
113 | L-serine transport (GO:0015825) | 2.69964516 |
114 | negative regulation of macrophage differentiation (GO:0045650) | 2.69669004 |
115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69122518 |
116 | regulation of necroptotic process (GO:0060544) | 2.68147259 |
117 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67281408 |
118 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.66498829 |
119 | positive regulation of interleukin-6 production (GO:0032755) | 2.66238087 |
120 | pentose-phosphate shunt (GO:0006098) | 2.65793720 |
121 | glycerolipid catabolic process (GO:0046503) | 2.65680483 |
122 | natural killer cell mediated immunity (GO:0002228) | 2.64329592 |
123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.64329592 |
124 | regulation of interleukin-12 production (GO:0032655) | 2.64234489 |
125 | regulation of heat generation (GO:0031650) | 2.63866661 |
126 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63649818 |
127 | regulation of p38MAPK cascade (GO:1900744) | 2.63433659 |
128 | positive regulation of protein deacetylation (GO:0090312) | 2.63245781 |
129 | positive regulation of interferon-alpha production (GO:0032727) | 2.62172733 |
130 | regulation of macrophage cytokine production (GO:0010935) | 2.61535033 |
131 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.61146759 |
132 | detection of other organism (GO:0098543) | 2.60795807 |
133 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.60755150 |
134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60239426 |
135 | granulocyte activation (GO:0036230) | 2.60145421 |
136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60026519 |
137 | regulation of macrophage chemotaxis (GO:0010758) | 2.59940048 |
138 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.59253545 |
139 | adhesion of symbiont to host cell (GO:0044650) | 2.58583234 |
140 | virion attachment to host cell (GO:0019062) | 2.58583234 |
141 | cellular response to lithium ion (GO:0071285) | 2.58287135 |
142 | negative regulation of necroptotic process (GO:0060546) | 2.56423907 |
143 | response to manganese ion (GO:0010042) | 2.55806520 |
144 | regulation of T cell tolerance induction (GO:0002664) | 2.55671416 |
145 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.54048961 |
146 | regulation of growth of symbiont in host (GO:0044126) | 2.54048961 |
147 | negative regulation of growth of symbiont in host (GO:0044130) | 2.54048961 |
148 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.54048961 |
149 | cellular response to biotic stimulus (GO:0071216) | 2.52903045 |
150 | dendritic cell differentiation (GO:0097028) | 2.52782079 |
151 | NADPH regeneration (GO:0006740) | 2.52180490 |
152 | glycosphingolipid catabolic process (GO:0046479) | 2.51898369 |
153 | carnitine transport (GO:0015879) | 2.51710570 |
154 | amino-acid betaine transport (GO:0015838) | 2.51710570 |
155 | regulation of RIG-I signaling pathway (GO:0039535) | 2.51379411 |
156 | protein localization to endosome (GO:0036010) | 2.50855897 |
157 | negative regulation of cell killing (GO:0031342) | 2.50532047 |
158 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50532047 |
159 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.50476676 |
160 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49417993 |
161 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49358193 |
162 | regulation of immunoglobulin secretion (GO:0051023) | 2.47604756 |
163 | response to lipoprotein particle (GO:0055094) | 2.47532794 |
164 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.46859468 |
165 | positive regulation by symbiont of host defense response (GO:0052509) | 2.45391523 |
166 | modulation by symbiont of host defense response (GO:0052031) | 2.45391523 |
167 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.45391523 |
168 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.45391523 |
169 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.45391523 |
170 | modulation by symbiont of host immune response (GO:0052553) | 2.45391523 |
171 | cortical actin cytoskeleton organization (GO:0030866) | 2.44353119 |
172 | positive regulation of lipid catabolic process (GO:0050996) | 2.43052592 |
173 | regulation of fatty acid oxidation (GO:0046320) | 2.42654952 |
174 | plasma lipoprotein particle clearance (GO:0034381) | 2.41568712 |
175 | regulation of response to interferon-gamma (GO:0060330) | 2.39571052 |
176 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.38380828 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.83966909 |
2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.01220029 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73020383 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60434762 |
5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.08584465 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05000505 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83009972 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71358549 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61116292 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57813497 |
11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.45568482 |
12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35888975 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34702580 |
14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21300171 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20791748 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12355496 |
17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07787426 |
18 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04901894 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02384601 |
20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02211530 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00373083 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96220990 |
23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90395899 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88663360 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85620292 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71050653 |
27 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70324688 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69297183 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67991371 |
30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62450668 |
31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62095102 |
32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59597325 |
33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.58801009 |
34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57336867 |
35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.56720564 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56118864 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54468821 |
38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52051380 |
39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48106216 |
40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47415610 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47028582 |
42 | * MAF_26560356_Chip-Seq_TH1_Human | 1.42794626 |
43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42650445 |
44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42577228 |
45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41970647 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41384557 |
47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41363166 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40151200 |
49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37445591 |
50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37368027 |
51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35017205 |
52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32008284 |
53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31658599 |
54 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30989133 |
55 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29646220 |
56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29117583 |
57 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.28531032 |
58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26362306 |
59 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.26167696 |
60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23904103 |
61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21426404 |
62 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20284279 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18477924 |
64 | MYC_22102868_ChIP-Seq_BL_Human | 1.16151477 |
65 | MYB_26560356_Chip-Seq_TH2_Human | 1.13163241 |
66 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12093914 |
67 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11436862 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11348470 |
69 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11065643 |
70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10913736 |
71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10203238 |
72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10123033 |
73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10093377 |
74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08232459 |
75 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.07634568 |
76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06860749 |
77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05548668 |
78 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05407420 |
79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04212436 |
80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04168285 |
81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03855861 |
82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03649097 |
83 | MYB_26560356_Chip-Seq_TH1_Human | 1.03372608 |
84 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02362605 |
85 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02362605 |
86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01046681 |
87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00913688 |
88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98241300 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95477360 |
90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95247636 |
91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95247636 |
92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95247636 |
93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94901630 |
94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93527224 |
95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93064512 |
96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93012399 |
97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92303057 |
98 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92125112 |
99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91624333 |
100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91249301 |
101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91191482 |
102 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91090512 |
103 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89757175 |
104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89658924 |
105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89487181 |
106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89483244 |
107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88627767 |
108 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88485646 |
109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87879964 |
110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87803174 |
111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86947809 |
112 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86420938 |
113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85944874 |
114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85849713 |
115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85813411 |
116 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83812905 |
117 | * MAF_26560356_Chip-Seq_TH2_Human | 0.82727718 |
118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82554800 |
119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82344340 |
120 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82248688 |
121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81471850 |
122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81285651 |
123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81285490 |
124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81209714 |
125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80831601 |
126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80760602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 5.25290559 |
2 | MP0002254_reproductive_system_inflammat | 4.76330591 |
3 | MP0005666_abnormal_adipose_tissue | 3.97482395 |
4 | MP0004185_abnormal_adipocyte_glucose | 3.76874354 |
5 | MP0004130_abnormal_muscle_cell | 3.55696646 |
6 | MP0005375_adipose_tissue_phenotype | 2.76701039 |
7 | MP0002166_altered_tumor_susceptibility | 2.49322848 |
8 | MP0002971_abnormal_brown_adipose | 2.47504102 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.38087005 |
10 | MP0002138_abnormal_hepatobiliary_system | 2.36765292 |
11 | MP0001835_abnormal_antigen_presentation | 2.32525292 |
12 | MP0009840_abnormal_foam_cell | 2.32061145 |
13 | MP0009115_abnormal_fat_cell | 2.29188370 |
14 | MP0004510_myositis | 2.16259799 |
15 | MP0008004_abnormal_stomach_pH | 2.12371834 |
16 | MP0003303_peritoneal_inflammation | 2.04023114 |
17 | MP0003724_increased_susceptibility_to | 2.01106445 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.00044051 |
19 | MP0008438_abnormal_cutaneous_collagen | 1.99245679 |
20 | MP0005451_abnormal_body_composition | 1.98499037 |
21 | MP0003436_decreased_susceptibility_to | 1.96996019 |
22 | MP0000685_abnormal_immune_system | 1.93280885 |
23 | MP0002006_tumorigenesis | 1.89431351 |
24 | MP0001790_abnormal_immune_system | 1.83696062 |
25 | MP0005387_immune_system_phenotype | 1.83696062 |
26 | MP0005334_abnormal_fat_pad | 1.82462701 |
27 | MP0002009_preneoplasia | 1.77550820 |
28 | MP0004858_abnormal_nervous_system | 1.69858632 |
29 | MP0000569_abnormal_digit_pigmentation | 1.67505398 |
30 | MP0002139_abnormal_hepatobiliary_system | 1.60078085 |
31 | MP0002970_abnormal_white_adipose | 1.58840576 |
32 | MP0001800_abnormal_humoral_immune | 1.50930071 |
33 | MP0000003_abnormal_adipose_tissue | 1.47423535 |
34 | MP0005166_decreased_susceptibility_to | 1.47349543 |
35 | MP0005000_abnormal_immune_tolerance | 1.46872373 |
36 | MP0002419_abnormal_innate_immunity | 1.46754997 |
37 | MP0010155_abnormal_intestine_physiology | 1.45146117 |
38 | MP0003045_fibrosis | 1.43527627 |
39 | MP0001348_abnormal_lacrimal_gland | 1.41269643 |
40 | MP0010329_abnormal_lipoprotein_level | 1.40568347 |
41 | MP0002452_abnormal_antigen_presenting | 1.40252068 |
42 | MP0003828_pulmonary_edema | 1.37510932 |
43 | MP0009785_altered_susceptibility_to | 1.36673491 |
44 | MP0003300_gastrointestinal_ulcer | 1.36433414 |
45 | MP0000013_abnormal_adipose_tissue | 1.35756067 |
46 | MP0001533_abnormal_skeleton_physiology | 1.35586678 |
47 | MP0003448_altered_tumor_morphology | 1.35282524 |
48 | MP0002332_abnormal_exercise_endurance | 1.35247694 |
49 | MP0008961_abnormal_basal_metabolism | 1.34250354 |
50 | MP0000858_altered_metastatic_potential | 1.32193956 |
51 | MP0005076_abnormal_cell_differentiation | 1.31428871 |
52 | MP0003690_abnormal_glial_cell | 1.30944070 |
53 | MP0001881_abnormal_mammary_gland | 1.30842593 |
54 | MP0001853_heart_inflammation | 1.30107643 |
55 | MP0002277_abnormal_respiratory_mucosa | 1.27123032 |
56 | MP0002723_abnormal_immune_serum | 1.26270418 |
57 | MP0002876_abnormal_thyroid_physiology | 1.24680535 |
58 | MP0005535_abnormal_body_temperature | 1.24390640 |
59 | MP0010352_gastrointestinal_tract_polyps | 1.22000151 |
60 | MP0001819_abnormal_immune_cell | 1.21248633 |
61 | MP0000343_altered_response_to | 1.20759105 |
62 | MP0005025_abnormal_response_to | 1.19126121 |
63 | MP0002420_abnormal_adaptive_immunity | 1.18689451 |
64 | MP0005058_abnormal_lysosome_morphology | 1.18554543 |
65 | MP0003329_amyloid_beta_deposits | 1.17646595 |
66 | MP0000609_abnormal_liver_physiology | 1.16643319 |
67 | MP0003566_abnormal_cell_adhesion | 1.15788536 |
68 | MP0005671_abnormal_response_to | 1.15371991 |
69 | MP0005275_abnormal_skin_tensile | 1.15222066 |
70 | MP0002148_abnormal_hypersensitivity_rea | 1.14201505 |
71 | MP0002998_abnormal_bone_remodeling | 1.14126564 |
72 | MP0003091_abnormal_cell_migration | 1.13866402 |
73 | MP0002118_abnormal_lipid_homeostasis | 1.11633838 |
74 | MP0000604_amyloidosis | 1.10094916 |
75 | MP0005023_abnormal_wound_healing | 1.10094234 |
76 | MP0006054_spinal_hemorrhage | 1.08681846 |
77 | MP0005310_abnormal_salivary_gland | 1.07366063 |
78 | MP0004947_skin_inflammation | 1.05914239 |
79 | MP0001542_abnormal_bone_strength | 1.04481461 |
80 | MP0001501_abnormal_sleep_pattern | 1.02263286 |
81 | MP0006082_CNS_inflammation | 1.01827365 |
82 | MP0000920_abnormal_myelination | 1.01699359 |
83 | MP0005390_skeleton_phenotype | 1.01601013 |
84 | MP0005448_abnormal_energy_balance | 1.00756623 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 0.99473970 |
86 | MP0000249_abnormal_blood_vessel | 0.98708790 |
87 | MP0005464_abnormal_platelet_physiology | 0.97149914 |
88 | MP0002396_abnormal_hematopoietic_system | 0.96756978 |
89 | MP0001879_abnormal_lymphatic_vessel | 0.96312266 |
90 | MP0000750_abnormal_muscle_regeneration | 0.95097207 |
91 | MP0003195_calcinosis | 0.94991631 |
92 | MP0008775_abnormal_heart_ventricle | 0.94750424 |
93 | MP0005165_increased_susceptibility_to | 0.94568180 |
94 | MP0002837_dystrophic_cardiac_calcinosis | 0.93273695 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.90872602 |
96 | MP0005164_abnormal_response_to | 0.90730517 |
97 | MP0009333_abnormal_splenocyte_physiolog | 0.90409805 |
98 | MP0008260_abnormal_autophagy | 0.90395728 |
99 | MP0005452_abnormal_adipose_tissue | 0.89890604 |
100 | MP0003183_abnormal_peptide_metabolism | 0.88964782 |
101 | MP0001851_eye_inflammation | 0.88792018 |
102 | MP0003075_altered_response_to | 0.88788230 |
103 | MP0000716_abnormal_immune_system | 0.87561281 |
104 | MP0004087_abnormal_muscle_fiber | 0.86951516 |
105 | MP0003959_abnormal_lean_body | 0.86278625 |
106 | MP0003646_muscle_fatigue | 0.86213146 |
107 | MP0005397_hematopoietic_system_phenotyp | 0.86150500 |
108 | MP0001545_abnormal_hematopoietic_system | 0.86150500 |
109 | MP0003172_abnormal_lysosome_physiology | 0.85943915 |
110 | MP0002933_joint_inflammation | 0.85879194 |
111 | MP0003279_aneurysm | 0.85115278 |
112 | MP0001873_stomach_inflammation | 0.84784008 |
113 | MP0002405_respiratory_system_inflammati | 0.84728222 |
114 | MP0004883_abnormal_blood_vessel | 0.84535969 |
115 | MP0000733_abnormal_muscle_development | 0.84528562 |
116 | MP0009763_increased_sensitivity_to | 0.84383246 |
117 | MP0000759_abnormal_skeletal_muscle | 0.84228758 |
118 | MP0003453_abnormal_keratinocyte_physiol | 0.83877029 |
119 | MP0002877_abnormal_melanocyte_morpholog | 0.83867164 |
120 | MP0009278_abnormal_bone_marrow | 0.79475904 |
121 | MP0005595_abnormal_vascular_smooth | 0.78898196 |
122 | MP0008469_abnormal_protein_level | 0.78812730 |
123 | MP0008874_decreased_physiological_sensi | 0.76342283 |
124 | MP0001845_abnormal_inflammatory_respons | 0.76195071 |
125 | MP0002398_abnormal_bone_marrow | 0.75231432 |
126 | MP0009764_decreased_sensitivity_to | 0.73624451 |
127 | MP0003634_abnormal_glial_cell | 0.71572152 |
128 | MP0009765_abnormal_xenobiotic_induced | 0.69807590 |
129 | MP0001663_abnormal_digestive_system | 0.69057218 |
130 | MP0005647_abnormal_sex_gland | 0.67393087 |
131 | MP0003795_abnormal_bone_structure | 0.66294154 |
132 | MP0001849_ear_inflammation | 0.66076039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Difficulty running (HP:0009046) | 5.28651960 |
2 | Oligomenorrhea (HP:0000876) | 4.87827572 |
3 | Acanthosis nigricans (HP:0000956) | 4.18930821 |
4 | Neurofibrillary tangles (HP:0002185) | 4.13254557 |
5 | Myocardial infarction (HP:0001658) | 4.06795209 |
6 | Hypertriglyceridemia (HP:0002155) | 3.97299436 |
7 | Dysostosis multiplex (HP:0000943) | 3.81837711 |
8 | Hydroxyprolinuria (HP:0003080) | 3.74612286 |
9 | Abnormality of proline metabolism (HP:0010907) | 3.74612286 |
10 | Loss of speech (HP:0002371) | 3.67441174 |
11 | Nuclear cataract (HP:0100018) | 3.60597450 |
12 | Disinhibition (HP:0000734) | 3.48031710 |
13 | Mutism (HP:0002300) | 3.47135673 |
14 | Stomatitis (HP:0010280) | 3.46855926 |
15 | Fatigue (HP:0012378) | 3.40066822 |
16 | Glomerulonephritis (HP:0000099) | 3.39850141 |
17 | Keratoconjunctivitis sicca (HP:0001097) | 3.39784995 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.38951528 |
19 | Hematochezia (HP:0002573) | 3.34175349 |
20 | Autoimmune thrombocytopenia (HP:0001973) | 3.32633999 |
21 | Increased connective tissue (HP:0009025) | 3.31130273 |
22 | Axonal loss (HP:0003447) | 3.23998449 |
23 | Cerebral inclusion bodies (HP:0100314) | 3.16703140 |
24 | Interstitial pulmonary disease (HP:0006530) | 3.15494004 |
25 | Complement deficiency (HP:0004431) | 3.14147260 |
26 | Systemic lupus erythematosus (HP:0002725) | 3.11938777 |
27 | Tetraparesis (HP:0002273) | 3.10551873 |
28 | Nasal polyposis (HP:0100582) | 3.08500035 |
29 | Eczematoid dermatitis (HP:0000976) | 3.07334453 |
30 | Myoglobinuria (HP:0002913) | 3.05714716 |
31 | Keratoconjunctivitis (HP:0001096) | 3.02182728 |
32 | Abnormality of the nasal mucosa (HP:0000433) | 2.98741932 |
33 | Orchitis (HP:0100796) | 2.88424128 |
34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.88175715 |
35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.88175715 |
36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.88175715 |
37 | Polycythemia (HP:0001901) | 2.81876665 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80171309 |
39 | Hyperglycinuria (HP:0003108) | 2.79974794 |
40 | Cerebral aneurysm (HP:0004944) | 2.79378854 |
41 | Recurrent viral infections (HP:0004429) | 2.77940253 |
42 | Hyporeflexia of lower limbs (HP:0002600) | 2.77761276 |
43 | Mucopolysacchariduria (HP:0008155) | 2.75768547 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75768547 |
45 | Colitis (HP:0002583) | 2.74565768 |
46 | Apathy (HP:0000741) | 2.74270344 |
47 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.73801390 |
48 | Recurrent fungal infections (HP:0002841) | 2.73552858 |
49 | Cortical dysplasia (HP:0002539) | 2.72486257 |
50 | Neuronal loss in central nervous system (HP:0002529) | 2.66570729 |
51 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.66518880 |
52 | Myositis (HP:0100614) | 2.65327547 |
53 | Peritonitis (HP:0002586) | 2.64712102 |
54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62861456 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.62861456 |
56 | Diminished motivation (HP:0000745) | 2.58843915 |
57 | Recurrent abscess formation (HP:0002722) | 2.56785054 |
58 | Recurrent bacterial skin infections (HP:0005406) | 2.53516554 |
59 | Frequent falls (HP:0002359) | 2.52633282 |
60 | Chronic otitis media (HP:0000389) | 2.47839583 |
61 | Increased IgE level (HP:0003212) | 2.47832341 |
62 | Multiple enchondromatosis (HP:0005701) | 2.46048446 |
63 | Gangrene (HP:0100758) | 2.45106672 |
64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44202817 |
65 | Exercise-induced myalgia (HP:0003738) | 2.43657769 |
66 | Hemorrhage of the eye (HP:0011885) | 2.42988326 |
67 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.42264225 |
68 | Pigmentary retinal degeneration (HP:0001146) | 2.41278388 |
69 | Facial diplegia (HP:0001349) | 2.40882935 |
70 | Type 1 muscle fiber predominance (HP:0003803) | 2.37543446 |
71 | Muscle fiber splitting (HP:0003555) | 2.33971007 |
72 | Increased serum ferritin (HP:0003281) | 2.30972927 |
73 | Parakeratosis (HP:0001036) | 2.28784084 |
74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26979709 |
75 | Gingivitis (HP:0000230) | 2.26065199 |
76 | Pulmonary infiltrates (HP:0002113) | 2.25900546 |
77 | Rhabdomyolysis (HP:0003201) | 2.24156052 |
78 | Exercise-induced muscle cramps (HP:0003710) | 2.24147404 |
79 | Muscle stiffness (HP:0003552) | 2.22705311 |
80 | Abnormality of complement system (HP:0005339) | 2.22094576 |
81 | Hemoptysis (HP:0002105) | 2.19912735 |
82 | Asymmetric septal hypertrophy (HP:0001670) | 2.18192925 |
83 | Amyloidosis (HP:0011034) | 2.17150149 |
84 | Thin bony cortex (HP:0002753) | 2.13457922 |
85 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09624540 |
86 | Chest pain (HP:0100749) | 2.09254443 |
87 | Supranuclear gaze palsy (HP:0000605) | 2.09136067 |
88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06650821 |
89 | Hand muscle atrophy (HP:0009130) | 2.05523160 |
90 | Increased cerebral lipofuscin (HP:0011813) | 2.04116856 |
91 | Inflammation of the large intestine (HP:0002037) | 2.01553463 |
92 | Polygenic inheritance (HP:0010982) | 1.96771957 |
93 | Polyneuropathy (HP:0001271) | 1.96588145 |
94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96112237 |
95 | Macroorchidism (HP:0000053) | 1.95651144 |
96 | Long foot (HP:0001833) | 1.94386495 |
97 | Retrobulbar optic neuritis (HP:0100654) | 1.93732237 |
98 | Optic neuritis (HP:0100653) | 1.93732237 |
99 | Abnormality of the periventricular white matter (HP:0002518) | 1.93203687 |
100 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93014754 |
101 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93014754 |
102 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93014754 |
103 | Vertigo (HP:0002321) | 1.92976714 |
104 | Subcapsular cataract (HP:0000523) | 1.92841003 |
105 | Esophageal varix (HP:0002040) | 1.91726971 |
106 | Aortic aneurysm (HP:0004942) | 1.91635789 |
107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91295671 |
108 | Purpura (HP:0000979) | 1.91077523 |
109 | Inappropriate behavior (HP:0000719) | 1.90593906 |
110 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90495773 |
111 | Cellulitis (HP:0100658) | 1.90161097 |
112 | Peripheral demyelination (HP:0011096) | 1.90124578 |
113 | Abnormality of glycine metabolism (HP:0010895) | 1.89931515 |
114 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89931515 |
115 | Skin nodule (HP:0200036) | 1.88595604 |
116 | Spondylolisthesis (HP:0003302) | 1.88362969 |
117 | Cerebral hemorrhage (HP:0001342) | 1.88004175 |
118 | Round ear (HP:0100830) | 1.87657213 |
119 | Eosinophilia (HP:0001880) | 1.87630567 |
120 | Abnormality of the fingertips (HP:0001211) | 1.87506139 |
121 | Progressive neurologic deterioration (HP:0002344) | 1.86854089 |
122 | Dementia (HP:0000726) | 1.86689429 |
123 | Nephritis (HP:0000123) | 1.86415692 |
124 | Periodontitis (HP:0000704) | 1.86258458 |
125 | Distal upper limb amyotrophy (HP:0007149) | 1.86136869 |
126 | Upper limb amyotrophy (HP:0009129) | 1.86136869 |
127 | Hyperkalemia (HP:0002153) | 1.85512585 |
128 | Increased IgM level (HP:0003496) | 1.84849196 |
129 | Gastrointestinal inflammation (HP:0004386) | 1.83156016 |
130 | Hypergammaglobulinemia (HP:0010702) | 1.81502451 |
131 | Mitral valve prolapse (HP:0001634) | 1.81402685 |
132 | Upper motor neuron abnormality (HP:0002127) | 1.80515506 |
133 | Recurrent skin infections (HP:0001581) | 1.80505327 |
134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80228528 |
135 | Arterial thrombosis (HP:0004420) | 1.79369475 |
136 | Basal ganglia calcification (HP:0002135) | 1.78854613 |
137 | Episodic fever (HP:0001954) | 1.78720269 |
138 | Broad metatarsal (HP:0001783) | 1.78380379 |
139 | Growth hormone excess (HP:0000845) | 1.78009058 |
140 | Malnutrition (HP:0004395) | 1.77665395 |
141 | Leukocytosis (HP:0001974) | 1.76649936 |
142 | Hyperparathyroidism (HP:0000843) | 1.76226442 |
143 | Visceral angiomatosis (HP:0100761) | 1.75786165 |
144 | Abnormality of iron homeostasis (HP:0011031) | 1.75632367 |
145 | Ulnar deviation of the wrist (HP:0003049) | 1.75604056 |
146 | Vasculitis (HP:0002633) | 1.73947110 |
147 | Acne (HP:0001061) | 1.73313519 |
148 | Abnormality of the endocardium (HP:0004306) | 1.73272344 |
149 | Abnormality of macrophages (HP:0004311) | 1.73186019 |
150 | Mediastinal lymphadenopathy (HP:0100721) | 1.73112351 |
151 | Memory impairment (HP:0002354) | 1.73111720 |
152 | Increased CSF protein (HP:0002922) | 1.73055373 |
153 | Insulin resistance (HP:0000855) | 1.71903581 |
154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70434483 |
155 | Bone pain (HP:0002653) | 1.70268003 |
156 | Vertebral compression fractures (HP:0002953) | 1.69955572 |
157 | Spontaneous hematomas (HP:0007420) | 1.69444262 |
158 | Abnormality of the pleura (HP:0002103) | 1.68416586 |
159 | Venous abnormality (HP:0002624) | 1.68024019 |
160 | Achilles tendon contracture (HP:0001771) | 1.67957092 |
161 | Glomerulopathy (HP:0100820) | 1.67947515 |
162 | Personality changes (HP:0000751) | 1.67490304 |
163 | Hepatosplenomegaly (HP:0001433) | 1.66450538 |
164 | Abnormality of the pericardium (HP:0001697) | 1.65101191 |
165 | Rapidly progressive (HP:0003678) | 1.64981373 |
166 | Thick nail (HP:0001805) | 1.64899996 |
167 | Arthralgia (HP:0002829) | 1.64461186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMK1D | 4.24840991 |
2 | TRIB3 | 3.36436695 |
3 | CAMK1G | 3.17165324 |
4 | MAP3K14 | 3.02991273 |
5 | PRPF4B | 2.89965109 |
6 | DDR2 | 2.85667121 |
7 | TYK2 | 2.72721026 |
8 | CDK12 | 2.68508946 |
9 | ERN1 | 2.62241558 |
10 | TAOK2 | 2.54445653 |
11 | GRK7 | 2.53441742 |
12 | MAP3K13 | 2.49695781 |
13 | SIK1 | 2.45201903 |
14 | TGFBR2 | 2.44623584 |
15 | JAK1 | 2.35454931 |
16 | CSF1R | 2.30770171 |
17 | FGFR3 | 2.27046703 |
18 | EPHB1 | 2.24480174 |
19 | RIPK1 | 2.10950271 |
20 | JAK3 | 2.04238431 |
21 | NME2 | 1.92146844 |
22 | IKBKB | 1.91810406 |
23 | MAP3K3 | 1.86125889 |
24 | TBK1 | 1.80716906 |
25 | TAOK1 | 1.79472609 |
26 | CDC42BPA | 1.68240240 |
27 | LATS2 | 1.58272775 |
28 | FGFR4 | 1.57611227 |
29 | MAP3K11 | 1.57045588 |
30 | * PRKAA2 | 1.55111940 |
31 | TTN | 1.54584674 |
32 | CHUK | 1.53186755 |
33 | GRK6 | 1.47331312 |
34 | BMPR2 | 1.35040623 |
35 | PIM2 | 1.34708132 |
36 | EPHA3 | 1.31111506 |
37 | MAP3K1 | 1.27475422 |
38 | IRAK2 | 1.27232211 |
39 | JAK2 | 1.27100840 |
40 | GRK5 | 1.26299080 |
41 | IKBKE | 1.24770521 |
42 | KIT | 1.23451049 |
43 | CSK | 1.16078098 |
44 | PHKG1 | 1.13589553 |
45 | PHKG2 | 1.13589553 |
46 | IRAK3 | 1.11850543 |
47 | BLK | 1.04503312 |
48 | MAP2K3 | 1.04318267 |
49 | PKN1 | 1.04297635 |
50 | MAP3K7 | 1.00865869 |
51 | PTK6 | 0.99930287 |
52 | ARAF | 0.99653068 |
53 | MAP3K10 | 0.99246803 |
54 | NEK9 | 0.96590162 |
55 | STK10 | 0.96076912 |
56 | SIK2 | 0.93887330 |
57 | TXK | 0.93402333 |
58 | FLT3 | 0.93262615 |
59 | CDK9 | 0.88641336 |
60 | WNK1 | 0.86808377 |
61 | RET | 0.85510616 |
62 | ABL2 | 0.85112983 |
63 | CDK6 | 0.84944704 |
64 | MAPK12 | 0.82499455 |
65 | MATK | 0.78694471 |
66 | BMX | 0.78349345 |
67 | RIPK4 | 0.78325977 |
68 | LMTK2 | 0.77178783 |
69 | GSK3A | 0.76453550 |
70 | MAP4K1 | 0.75397137 |
71 | ICK | 0.75149981 |
72 | MAP3K9 | 0.71441372 |
73 | PDK3 | 0.70249436 |
74 | PDK4 | 0.70249436 |
75 | INSRR | 0.69552331 |
76 | HCK | 0.69024673 |
77 | MAPK4 | 0.67821950 |
78 | TYRO3 | 0.67517749 |
79 | CLK1 | 0.66821553 |
80 | BCKDK | 0.66181401 |
81 | MTOR | 0.65790873 |
82 | KSR2 | 0.65024878 |
83 | MOS | 0.64105886 |
84 | MAP3K5 | 0.63262177 |
85 | LYN | 0.62155116 |
86 | FES | 0.58911445 |
87 | FGFR2 | 0.58737637 |
88 | IRAK4 | 0.58522923 |
89 | PDK1 | 0.56554416 |
90 | SIK3 | 0.56272458 |
91 | FGR | 0.56143663 |
92 | IRAK1 | 0.55910329 |
93 | EIF2AK2 | 0.55421518 |
94 | LCK | 0.55144968 |
95 | STK11 | 0.54863875 |
96 | PDPK1 | 0.54862151 |
97 | DMPK | 0.54273953 |
98 | ZAP70 | 0.53746431 |
99 | MARK2 | 0.53075888 |
100 | PDGFRA | 0.51354089 |
101 | SYK | 0.51033121 |
102 | MAPK7 | 0.50164909 |
103 | TESK1 | 0.49185448 |
104 | MAP3K6 | 0.48981248 |
105 | PKN2 | 0.48574210 |
106 | INSR | 0.48193313 |
107 | PDGFRB | 0.47969869 |
108 | * PRKAA1 | 0.47655777 |
109 | STK3 | 0.47556496 |
110 | PDK2 | 0.47268206 |
111 | MST1R | 0.47161464 |
112 | PIK3CA | 0.46440044 |
113 | PTK2B | 0.46432670 |
114 | IGF1R | 0.46017611 |
115 | SGK1 | 0.45482194 |
116 | ADRBK2 | 0.45280810 |
117 | HIPK2 | 0.45160867 |
118 | RPS6KC1 | 0.44601021 |
119 | RPS6KL1 | 0.44601021 |
120 | ITK | 0.43918638 |
121 | PRKG2 | 0.43682178 |
122 | SGK3 | 0.43081405 |
123 | MAPKAPK2 | 0.42706664 |
124 | ALK | 0.42468824 |
125 | EPHB2 | 0.41634668 |
126 | MAP2K6 | 0.41396741 |
127 | ABL1 | 0.40603327 |
128 | RPS6KA2 | 0.39941824 |
129 | DAPK2 | 0.39789710 |
130 | MAPK11 | 0.37486051 |
131 | MARK3 | 0.36311816 |
132 | PAK4 | 0.35728898 |
133 | PAK2 | 0.35235329 |
134 | CAMK4 | 0.35048834 |
135 | EEF2K | 0.31061429 |
136 | RPS6KA6 | 0.30188431 |
137 | PIM1 | 0.29987480 |
138 | BTK | 0.29443954 |
139 | FYN | 0.28260146 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.50631802 |
2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.81981852 |
3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.45980249 |
4 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.38406691 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33963780 |
6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.30885429 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08905549 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97096447 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93987216 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87752947 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80138310 |
12 | Insulin resistance_Homo sapiens_hsa04931 | 1.72298875 |
13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70948969 |
14 | Prion diseases_Homo sapiens_hsa05020 | 1.59509923 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58221924 |
16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.56617252 |
17 | Asthma_Homo sapiens_hsa05310 | 1.54858954 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54080139 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53026077 |
20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52008245 |
21 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.45993244 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42782585 |
23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41825634 |
24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33675959 |
25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31771309 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29123908 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27912583 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24584091 |
29 | Measles_Homo sapiens_hsa05162 | 1.23753485 |
30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23501698 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.22303827 |
32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22203641 |
33 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.21308373 |
34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18861505 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15860742 |
36 | Bladder cancer_Homo sapiens_hsa05219 | 1.14895941 |
37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12083637 |
38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07735115 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06183560 |
40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05384642 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05028160 |
42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04746349 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04304660 |
44 | Renin secretion_Homo sapiens_hsa04924 | 1.04025545 |
45 | Pertussis_Homo sapiens_hsa05133 | 1.03061145 |
46 | Phagosome_Homo sapiens_hsa04145 | 1.02642583 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02590319 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02330079 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 1.01226080 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00048944 |
51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98329230 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97047892 |
53 | Influenza A_Homo sapiens_hsa05164 | 0.94913842 |
54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92108960 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88044518 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.87921483 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87515462 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86824764 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86370770 |
60 | Malaria_Homo sapiens_hsa05144 | 0.84370648 |
61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84093161 |
62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84001441 |
63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83972070 |
64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83532733 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82663574 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82039613 |
67 | Legionellosis_Homo sapiens_hsa05134 | 0.81433340 |
68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80984011 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80672944 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78966436 |
71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78037758 |
72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77489366 |
73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76116991 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72756891 |
75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71191470 |
76 | Platelet activation_Homo sapiens_hsa04611 | 0.68710873 |
77 | Focal adhesion_Homo sapiens_hsa04510 | 0.68269285 |
78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67744171 |
79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67528233 |
80 | Lysosome_Homo sapiens_hsa04142 | 0.67146140 |
81 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66926489 |
82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66458211 |
83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64784354 |
84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64440106 |
85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63955873 |
86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63807804 |
87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63555850 |
88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62844514 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62717106 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61979965 |
91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61090679 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60718782 |
93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60417169 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58831394 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.58267342 |
96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58239546 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.57470163 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57187681 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55733724 |
100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55691982 |
101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53270073 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52967518 |
103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52395167 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51768169 |
105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51573634 |
106 | Allograft rejection_Homo sapiens_hsa05330 | 0.51080185 |
107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50323013 |
108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49260205 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49112812 |
110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48641518 |
111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48385292 |
112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47826544 |
113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47455430 |
114 | Salmonella infection_Homo sapiens_hsa05132 | 0.47196688 |
115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46961181 |
116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46025828 |
117 | Shigellosis_Homo sapiens_hsa05131 | 0.45685264 |
118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45155168 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44994422 |
120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44900699 |
121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43536600 |
122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42117271 |
123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41165560 |
124 | Endocytosis_Homo sapiens_hsa04144 | 0.38404909 |
125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36659408 |
126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32543346 |
127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32397452 |